Since NT5E gene response to TNF-α/NFκB appeared to inversely correlate with PPARγ, we hypothesize that also in CRC PPARγ counteracts TNF-α/NFκB activation, likely through a transrepression mechanism [40]. The gene discussed is TNF; the disease is colorectal carcinoma.